Skip to main content
. 2013 Mar;15(2):196–209. doi: 10.1016/j.jmoldx.2012.09.006

Figure 3.

Figure 3

Kaplan-Meier curves of time-to-event outcomes. A: Kaplan-Meier curves describing the time-to-treatment function in 36 patients with three or more CNVs versus 57 patients with two CNVs versus 60 patients with one CNV versus 13 patients with 0 CNVs. Considered in this analysis were 14 segments of CNV, independently associated with TTT. B: Kaplan-Meier curves describing the time-to-treatment function in 20 patients with two or more CNVs versus 66 patients with one CNV versus 82 patients without any CNV. Included in this analysis were three CLL-specific segments of CNV, independently associated with TTT. C: Kaplan-Meier curves describing the survival function in 15 patients with two or more CNVs versus 55 patients with one CNV versus 98 patients without any CNV. Considered in this analysis were nine segments of CNV that independently associated with OS. D: Kaplan-Meier curves describing the survival function in 16 patients with one or more CNVs versus 150 patients without any CNV. Considered in this analysis was only one CLL-specific segment of CNV (del6q27) that independently predicted OS. ab., abnormality.